On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to FDA Guidance on ZIKV Testing Strategy. Please register for CTS FDA Guidance ZIKV Testing Strategy Webinar by clicking the link: CTS FDA Guidance ZIKV Testing Strategy Webinar
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...